Franz et al v. Takeda Pharmaceuticals U.S.A., Inc. et al
| Eyvonne G. Franz and Rebecca Caulder |
| Jane Doe, Takeda Global Research And Development Center, Inc., Eli Lilly & Company, John Doe, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International, Inc., Takeda Pharmaceuticals, LLC, Takeda Pharmaceuticals America, Inc. and Takeda California, Inc. |
| 3:2020cv00890 |
| February 28, 2020 |
| US District Court for the District of South Carolina |
| Mary Geiger Lewis |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1441 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 20, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 15
ORDER DISMISSING CASE without costs and without prejudice to the right of any party, upon good cause shown within ninety (90) days, to reinstate the action if settlement is not consummated. Signed by Honorable Mary Geiger Lewis on 4/20/2020. (cbru, )
|
| Filing 14 MOTION for Entry of "Rubin" Order by Rebecca Caulder, Eli Lilly & Company, Eyvonne G. Franz, Takeda California, Inc., Takeda Global Research And Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International, Inc., Takeda Pharmaceuticals U.S.A., Inc.. Response to Motion due by 5/4/2020. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: #1 Proposed Order)Proposed order is being emailed to chambers with copy to opposing counsel. Filing corrected for event type (cbru, ) |
| Filing 12 TEXT ORDER granting #11 MOTION to Stay. The parties are hereby directed to file a joint report apprising the Court as to the status of this action no later than April 27, 2019. IT IS SO ORDERED. (Status Report due by 4/27/2020) Signed by Honorable Mary Geiger Lewis on 3/26/2020. (cbru, ) |
| Filing 11 Joint MOTION to Stay by Rebecca Caulder, Eyvonne G. Franz. Response to Motion due by 4/9/2020. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: #1 Proposed Order)Proposed order is being emailed to chambers with copy to opposing counsel. Filing corrected for event type (cbru, ) |
| Filing 9 CLERK'S NOTICE: Plaintiffs are reminded that Answers to Local Rule 26.01 Interrogatories are to be filed no later than 14 days after service of the notice of removal. Please file these answers to interrogatories no later than March 30, 2020. (cbru, ) |
| Filing 8 MEDIATION ORDER. Signed by Honorable Mary Geiger Lewis on 3/6/2020. (cbru, ) |
| Filing 7 CONFERENCE AND SCHEDULING ORDER: Rule 26 Report due by 4/9/2020, Motions to Amend Pleadings due by 5/5/2020, Plaintiffs ID of Expert Witness due by 6/4/2020, Defendants ID of Expert Witnesses Due by 7/6/2020, Records Custodian Affidavit due by 7/6/2020, Discovery due by 9/2/2020, Motion in Limine due by 12/16/2020, Motions due by 9/17/2020, Rule 26(a)(3) Disclosures due by 12/1/2020, Jury Selection Deadline 1/6/2021, Mediation Due by 11/16/2020. Signed by Honorable Mary Geiger Lewis on 3/6/2020. (cbru, ) |
| Filing 6 ANSWER to Complaint by Eli Lilly & Company, Takeda California, Inc., Takeda Global Research And Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Rawl, A) (Main Document 6 replaced on 3/6/2020) (cbru, ). |
| Filing 4 Local Rule 26.01 Answers to Interrogatories by Takeda California, Inc., Takeda Global Research And Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International, Inc., Takeda Pharmaceuticals U.S.A., Inc.(cbru, ) |
| Filing 3 Local Rule 26.01 Answers to Interrogatories by Eli Lilly & Company.(cbru, ) |
| Filing 1 NOTICE OF REMOVAL from Richland County Court of Common, case number 2019-CP-40-06323 (Filing fee $400 receipt number 0420-8974904) filed by Takeda Pharmaceuticals America, Inc., Eli Lilly & Company, Takeda Pharmaceuticals International, Inc., Takeda Global Research And Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda California, Inc., Takeda Pharmaceuticals U.S.A., Inc. (Attachments: #1 Exhibit A - State Court Documents, #2 Certificate of Service)(cbru, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the South Carolina District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
